DCs from breast cancer patients pulsed with tumour-specific lysate and matured with Ampligen®, an IFN-containing cocktail and R848 or IFN-containing cocktail alone express high levels of key co-stimulatory molecules. This evidence concerns the gene IFNA1 and breast cancer.